Author

Julie I Tange

Observed names: J Tange, J.I. TANGE, Julie I. Tange, Julie Irene Tange, Julie Tange

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5017202828

Left Atrial Blood Stasis and Von Willebrand Factor–ADAMTS13 Homeostasis in Atrial Fibrillation

2011 · Naser Ammash, Ewa A. Konik, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 57

Validation of an automated latex particle–enhanced immunoturbidimetric von Willebrand factor activity assay

2011 · D. CHEN, J.I. TANGE, et al. · Journal of Thrombosis and Haemostasis · 51

PDF

Local Verification and Assignment of Mean Normal Prothrombin Time and International Sensitivity Index Values across Various Instruments: Recent Experience and Outcome from North America

2013 · Julie Tange, Diane Grill, et al. · Seminars in Thrombosis and Hemostasis · 28

Heat inactivation of extended half‐life factor VIII concentrates

2019 · Kara A. Fylling, Julie I. Tange, et al. · Haemophilia · 8

Effect of residual platelets in frozen-thawed plasma on results of dilute Russell’s viper venom time assay for lupus anticoagulant testing

2023 · Brenda J Nelson Strande, Meera Sridharan, et al. · American Journal of Clinical Pathology · 5

PDF

Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients

2021 · Julie Goswami, Taleen A. MacArthur, et al. · Thrombosis Update · 3

Sialic acid–bearing paraproteins are implicated in heparin-like coagulopathy in patients with myeloma

2020 · Abdulrahman Saadalla, Jansen Seheult, et al. · Blood · 3

An Age Distribution of D-Dimer Values in Normal Healthy Donor Population: An Indirect Verification of the Age-Adjusted D-Dimer Cutoffs for VTE Exclusion

2016 · Rachel Leger, Sandra c Bryant, et al. · Blood · 3

Low ADAMTS13 Activity in Patients with Liver Disease- Thrombotic Thrombocytopenic Purpura or Not?

2023 · Meera Sridharan, Melissa S Stuart, et al. · Blood · 2

Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology

2024 · Jeremy W Jacobs, Melissa S Stuart, et al. · American Journal of Clinical Pathology · 1

PDF

Conformation-specific RNA aptamers for phenotypic distinction between normal von Willebrand factor and type 2B von Willebrand disease

2024 · Venkata R Machha, Alexander Tischer, et al. · NAR Molecular Medicine · 1

A-250 A MALDI mass spectrometry-based assay for the determination of ADAMTS13 activity

2026 · Olajide Olaleye, Sandip Chavan, et al. · Clinical Chemistry

A targeted mass spectrometric assay for quantitative detection of fibrinogen in plasma

2026 · Sandip Chavan, Ramesh Bokka, et al. · Research and Practice in Thrombosis and Haemostasis

PDF

A Targeted LC-MS/MS–Based Quantitative Assay for Detecting Plasma Factor XIII A/B Subunit Deficiency

2025 · Jinyong Kim, Shilpa Venkataraman, et al. · Journal of Molecular Diagnostics

Coagulation Pediatric Reference Interval Study: Procoagulant Proteins Preliminary Findings

2024 · Julie I Tange, Hunter Atkinson, et al. · Blood

PDF

A-144 Liquid chromatography multiple reaction monitoring-based assay for quantitative assessment of fibrinogen levels in clinical samples

2024 · S Chavan, R Bokka, et al. · Clinical Chemistry

PDF

An In Silico Exploration of the Factors That Affect the Precision of the Bethesda Assay

2020 · Jansen N Seheult, Laynalee Cardel, et al. · American Journal of Clinical Pathology

Works count: 17

Citation count: 162

H-index: 5

I10-index: 3